Skip to main content
. Author manuscript; available in PMC: 2012 Mar 2.
Published in final edited form as: Int J Tuberc Lung Dis. 2011 Jul;15(7):899–905. doi: 10.5588/ijtld.10.0556

Table 2.

Characteristics of TB cases, Group 1 and Group 2, 1986–2004

Group 1
Epidemic t0 < 1920
Group 2
Epidemic t0 > 1920
P valuea
Total number of TB cases 228 1243
Age category, number (%) <0.001
 <5 years 82 (36) 456 (37)
 5–9 26 (11) 184 (15)
 10–34 47 (21) 434 (35)
 35–64 49 (22) 122 (10)
 ≥65 24 (11) 47 (4)
Median age (range) 11 (4mo-84y) 9 (2mo-88y) <0.001
Male, number (%) 124 (54) 649 (52) 0.48
Disease category, number (%)b 0.21
 pulmonary 164 (80) 931 (85)
 extra-pulmonary 29 (14) 133 (12)
 disseminated 11 (5) 36 (3)
Cavitary pneumonia (%)c 13/206 (6) 90/1117 (8) 0.92
Relapse or reinfection (%)d 13 (6) 100 (8) 0.22
Documented reinfection (new strain)e 0 4
History of LTBI treatment (%)f 5 (2) 26 (2) 0.95
History of BCG (%) 108 (47) 700 (56) 0.01
Sputum smear positive (%)g 44/104 (42) 231/513 (45) 0.44
Culture positive (%)h 81/180 (45) 475/1042 (46) 0.88
Medical risk factor identified (%)i 19 (8) 9 (0.7) <0.001
Identified by screening (%)j 99/227 (44) 580/1240 (47) 0.31
a

Wilcoxon rank-sum or chi-square test. Unless otherwise indicated, the denominator for the proportions is the total number of TB cases in each group. Detailed descriptions of variables are in Methods and SOM.

b

Disease category data (pulmonary, extra-pulmonary, or disseminated) were available from 204 of the Group 1 cases and 1100 of the Group 2 cases. Percentages reported are proportion of cases from which disease classification data were available.

c

Cavity identified on chest X ray/cases for which chest X ray results were available.

d

History of discrete tuberculosis disease episode a minimum of 2 years prior to the current diagnosis

e

Bacteria with ≥ 2 distinct RFLP types isolated from a single individual during distinct disease episodes. RFLP types differed by ≥5 bands. Denominator is the total number of cases within the group for which RFLP typing data were available.

f

History of treatment for latent tuberculosis infection

g

Number of sputum smear specimens with acid fast bacilli/number of sputum smear examinations recorded

h

Number of patient specimens with M.tuberculosis identified in culture/number of tests recorded (≤1 specimen/case)

i

Risk factor for tuberculosis identified in medical history. Risk factors included HIV infection, malignancy, renal failure, diabetes mellitus, and treatment with corticosteroids. No data were recorded regarding use of tobacco, alcohol or other recreational drugs.

j

Case identified during through active surveillance, such as contact tracing investigations, tuberculin skin testing surveys, or population-based screens for tuberculosis disease. Denominator is number of cases for which these data were available.